Cargando…

Parkinson's Disease with Fatigue: Clinical Characteristics and Potential Mechanisms Relevant to α-Synuclein Oligomer

BACKGROUND AND PURPOSE: The aim of this study was to identify the clinical characteristics and potential mechanisms relevant to pathological proteins in Parkinson's disease (PD) patients who experience fatigue. METHODS: PD patients (n=102) were evaluated using a fatigue severity scale and scale...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zuo, Li-Jun, Yu, Shu-Yang, Wang, Fang, Hu, Yang, Piao, Ying-Shan, Du, Yang, Lian, Teng-Hong, Wang, Rui-Dan, Yu, Qiu-Jin, Wang, Ya-Jie, Wang, Xiao-Min, Chan, Piu, Chen, Sheng-Di, Wang, Yongjun, Zhang, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Neurological Association 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4828563/ https://www.ncbi.nlm.nih.gov/pubmed/26869370 http://dx.doi.org/10.3988/jcn.2016.12.2.172

Ejemplares similares

Serotonergic dysfunctions and abnormal iron metabolism: Relevant to mental fatigue of Parkinson disease
por: Zuo, Li-Jun, et al.
Publicado: (2016)

The Role of α-Synuclein Oligomers in Parkinson’s Disease
por: Du, Xiao-yu, et al.
Publicado: (2020)

Parkinson disease with constipation: clinical features and relevant factors
por: Yu, Qiu-Jin, et al.
Publicado: (2018)

Single-Molecule Detection of α-Synuclein Oligomers in Parkinson’s Disease Patients Using Nanopores
por: Liu, Yaxian, et al.
Publicado: (2023)

Phenotype of postural instability/gait difficulty in Parkinson disease: relevance to cognitive impairment and mechanism relating pathological proteins and neurotransmitters
por: Zuo, Li-Jun, et al.
Publicado: (2017)

An antibody scanning method for the detection of α-synuclein oligomers in the serum of Parkinson's disease patients
por: Kulenkampff, Klara, et al.
Publicado: (2022)

Extracellular Alpha-Synuclein Oligomers Induce Parkin S-Nitrosylation: Relevance to Sporadic Parkinson’s Disease Etiopathology
por: Wilkaniec, Anna, et al.
Publicado: (2018)

DJ-1 Acts as a Scavenger of α-Synuclein Oligomers and Restores Monomeric Glycated α-Synuclein
por: Atieh, Tamr B., et al.
Publicado: (2021)

Structural characteristics and membrane interactions of tandem α-synuclein oligomers
por: Dong, Chunhua, et al.
Publicado: (2018)

α-Synuclein oligomers in skin biopsy of idiopathic and monozygotic twin patients with Parkinson’s disease
por: Mazzetti, Samanta, et al.
Publicado: (2020)

Tremor-Dominant in Parkinson Disease: The Relevance to Iron Metabolism and Inflammation
por: Lian, Teng-Hong, et al.
Publicado: (2019)

Quantifying Co-Oligomer Formation by α-Synuclein
por: Iljina, Marija, et al.
Publicado: (2018)

Stabilization of α-synuclein oligomers using formaldehyde
por: Ruesink, Harm, et al.
Publicado: (2019)

Age- and brain region-dependent α-synuclein oligomerization is attributed to alterations in intrinsic enzymes regulating α-synuclein phosphorylation in aging monkey brains
por: Chen, Min, et al.
Publicado: (2015)

Receptor-Dependent Endocytosis Mediates α-Synuclein Oligomer Transport Into Red Blood Cells
por: Li, Wei, et al.
Publicado: (2022)

Elevated Levels of α-Synuclein Oligomer in the Cerebrospinal Fluid of Drug-Naïve Patients with Parkinson's Disease
por: Park, Min Jeong, et al.
Publicado: (2011)

α-synuclein oligomers interact with ATP synthase and open the permeability transition pore in Parkinson’s disease
por: Ludtmann, Marthe H. R., et al.
Publicado: (2018)

Modeling Parkinson’s Disease Neuropathology and Symptoms by Intranigral Inoculation of Preformed Human α-Synuclein Oligomers
por: Boi, Laura, et al.
Publicado: (2020)

Phosphorylation of α-synuclein at T64 results in distinct oligomers and exerts toxicity in models of Parkinson’s disease
por: Matsui, Hideaki, et al.
Publicado: (2023)

Investigation on Abnormal Iron Metabolism and Related Inflammation in Parkinson Disease Patients with Probable RBD
por: Hu, Yang, et al.
Publicado: (2015)

Structural and functional properties of prefibrillar α-synuclein oligomers
por: Pieri, Laura, et al.
Publicado: (2016)

Optical Structural Analysis of Individual α‐Synuclein Oligomers
por: Varela, Juan A., et al.
Publicado: (2018)

Mapping Surface Hydrophobicity of α-Synuclein Oligomers at the Nanoscale
por: Lee, Ji-Eun, et al.
Publicado: (2018)

α-Synuclein oligomers and fibrils: partners in crime in synucleinopathies
por: Bigi, Alessandra, et al.
Publicado: (2023)

Salivary total α-synuclein, oligomeric α-synuclein and SNCA variants in Parkinson’s disease patients
por: Kang, Wenyan, et al.
Publicado: (2016)

Restless legs syndrome in Parkinson disease: Clinical characteristics, abnormal iron metabolism and altered neurotransmitters
por: Piao, Ying-Shan, et al.
Publicado: (2017)

Altered machinery of protein synthesis is region- and stage-dependent and is associated with α-synuclein oligomers in Parkinson’s disease
por: Garcia-Esparcia, Paula, et al.
Publicado: (2015)

α‐Synuclein aggregation causes muscle atrophy through neuromuscular junction degeneration
por: Yang, Qiumei, et al.
Publicado: (2022)

Dopamine induces soluble α-synuclein oligomers and nigrostriatal degeneration
por: Mor, Danielle E., et al.
Publicado: (2017)

Photo-Induced Cross-Linking of Unmodified α-Synuclein Oligomers
por: Ortigosa-Pascual, Lei, et al.
Publicado: (2023)

Interaction between Neuromelanin and Alpha-Synuclein in Parkinson’s Disease
por: Xu, Shengli, et al.
Publicado: (2015)

α-Synuclein-carrying astrocytic extracellular vesicles in Parkinson pathogenesis and diagnosis
por: Wang, Pan, et al.
Publicado: (2023)

Biomarkers and the Role of α-Synuclein in Parkinson’s Disease
por: Du, Tingting, et al.
Publicado: (2021)

Clinical features and dysfunctions of iron metabolism in Parkinson disease patients with hyper echogenicity in substantia nigra: a cross-sectional study
por: Yu, Shu-yang, et al.
Publicado: (2018)

EGCG-mediated Protection of the Membrane Disruption and Cytotoxicity Caused by the ‘Active Oligomer’ of α-Synuclein
por: Yang, Jee Eun, et al.
Publicado: (2017)

Morphological Evaluation of Meta-stable Oligomers of α-Synuclein with Small-Angle Neutron Scattering
por: Bhak, Ghibom, et al.
Publicado: (2018)

α-Synuclein Oligomers Induced by Docosahexaenoic Acid Affect Membrane Integrity
por: Fecchio, Chiara, et al.
Publicado: (2013)

Intracellular soluble α‐synuclein oligomers reduce pyramidal cell excitability
por: Kaufmann, Timothy J., et al.
Publicado: (2016)

Tau oligomers mediate α-synuclein toxicity and can be targeted by immunotherapy
por: Gerson, Julia E., et al.
Publicado: (2018)

ELISA method to detect α-synuclein oligomers in cell and animal models
por: Lassen, Louise Berkhoudt, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_bfnolktc46g664ronms637n2dq